PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci179917 ↗Kurz gefasst
Korrektur in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Annalisa D'Avola und 16 weiteren Autor:innen. Hauptthemen laut MEDLINE: Lymphoma, Large B-Cell, Diffuse. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
comprehensive characterization of the role of the serine synthesis pathway in germinal center B cells lymphomas derived from these cells. We demonstrate that upregulation of a functional serine synthesis cell activation the center reaction. of dehydrogenase enzyme high levels of expression being predictive of reduced overall survival in diffuse large B cell lymphoma. Inhibition of PHGDH induced apoptosis in lymphoma cells, reducing disease progression. These findings establish PHGDH as a critical player in humoral immunity and a clinically relevant target in lymphoma. production, and generation of oncometabolites such as D-2-hydroxyglutarate (53). Taken together, this work provides important evidence that PHGDH is a viable target for the treatment of pathological B cell proliferation, either for the modulation of humoral immunity or in lymphoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
D'Avola, A., Legrave, N., Tajan, M., Chakravarty, P., Shearer, R. L., King, H. W., Kluckova, K., Cheung, E. C., Clear, A. J., Gunawan, A. S., Zhang, L., James, L. K., MacRae, J. I., Gribben, J. G., Calado, D. P., Vousden, K. H., & Riches, J. C. (2024). PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. Journal of Clinical Investigation. https://doi.org/10.1172/jci179917
Vancouver
D'Avola A, Legrave N, Tajan M, Chakravarty P, Shearer RL, King HW, et al. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma. Journal of Clinical Investigation. 2024. doi:10.1172/jci179917
BibTeX
@article{DAvola2024,
author = {D'Avola, Annalisa and Legrave, Nathalie and Tajan, Mylène and Chakravarty, Probir and Shearer, Ryan L and King, Hamish W and Kluckova, Katarina and Cheung, Eric C and Clear, Andrew J and Gunawan, Arief S and Zhang, Lingling and James, Louisa K and MacRae, James I and Gribben, John G and Calado, Dinis P and Vousden, Karen H and Riches, John C},
title = {PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci179917}
}
EUVIMED